Terms: = Sarcomas AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Prognosis
111 results:
1. Is there a prognostic difference among stage I lung adenocarcinoma patients with different braf-mutation status?
Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
[TBL] [Abstract] [Full Text] [Related]
2. Colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype.
Golconda U; McHugh KE; Allende DS; Collins K; Henn P; Lacambra M; Bejarano PA; Groisman GM; Loughrey MB; Monappa V; Zhang X; Hornick JL; Gonzalez RS
Am J Surg Pathol; 2024 Apr; 48(4):465-474. PubMed ID: 38155543
[TBL] [Abstract] [Full Text] [Related]
3. A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::braf fusion: a case report and literature review.
Zhang L; Zhang G; Zheng H; Jiang B; Ju Y; Duan Q; An L; Shi H
Brain Tumor Pathol; 2024 Jan; 41(1):18-29. PubMed ID: 38100030
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
Zhang J; Tian H; Mao L; Si L
Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
[TBL] [Abstract] [Full Text] [Related]
5. [Research Progress of braf Fusion in Non-small Cell Lung Cancer].
Xiao P; Zhong D
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):782-788. PubMed ID: 37989341
[TBL] [Abstract] [Full Text] [Related]
6. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
7. A Real-World Retrospective Study to Evaluate the Reliability of Cetuximab plus Capecitabine versus Capecitabine as Maintenance Therapy in Patients with RAS and braf Wild-Type Metastatic Colorectal Cancer.
Li J; Zhang H; Guo X; Dong S; Li Y; Huang W; Yuan X
Med Princ Pract; 2024; 33(1):31-40. PubMed ID: 37725905
[TBL] [Abstract] [Full Text] [Related]
8. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
10. Outcomes in patients with
Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto PA; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
Tumori; 2023 Dec; 109(6):537-545. PubMed ID: 37417313
[TBL] [Abstract] [Full Text] [Related]
11. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling.
Giner F; Machado I; Rubio-Martínez LA; López-Guerrero JA; Claramunt-Alonso R; Navarro S; Ferrández A; Mayordomo-Aranda E; Llombart-Bosch A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108696
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
13. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
14. braf V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.
Ricco G; Seminerio R; Andrini E; Malvi D; Gruppioni E; Altimari A; Zagnoni S; Campana D; Lamberti G
Anticancer Drugs; 2023 Nov; 34(10):1076-1084. PubMed ID: 36847048
[TBL] [Abstract] [Full Text] [Related]
15. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective.
Neuzillet C; Artru P; Assenat E; Edeline J; Adhoute X; Sabourin JC; Turpin A; Coriat R; Malka D
Target Oncol; 2023 Jan; 18(1):51-76. PubMed ID: 36745342
[TBL] [Abstract] [Full Text] [Related]
16. Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
Dai J; Bai X; Gao X; Tang L; Chen Y; Sun L; Wei X; Li C; Qi Z; Kong Y; Cui C; Chi Z; Sheng X; Xu Z; Lian B; Li S; Yan X; Tang B; Zhou L; Wang X; Xia X; Guo J; Mao L; Si L
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593066
[TBL] [Abstract] [Full Text] [Related]
17. A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer.
Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
[TBL] [Abstract] [Full Text] [Related]
18. Prevalence and detection of actionable braf V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR.
Kao EY; Wakeman KM; Wu Y; Gross JM; Chen EY; Ricciotti RW; Liu YJ; Mantilla JG
Hum Pathol; 2022 Nov; 129():90-97. PubMed ID: 36067829
[TBL] [Abstract] [Full Text] [Related]
19. prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Bridgewater J; Jiao X; Parimi M; Flach C; Stratford J; Kamburov A; Schmitz AA; Zong J; Reeves JA; Keating K; Bruno A; Fellous M; Pereira MB; Bazhenova L
Cancer Treat Res Commun; 2022; 33():100623. PubMed ID: 36041373
[TBL] [Abstract] [Full Text] [Related]
20. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
[TBL] [Abstract] [Full Text] [Related]
[Next]
